Odyssey Therapeutics
About:
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Website: https://odysseytx.com
Twitter/X: odyssey_tx
Top Investors: General Catalyst, Fidelity, OrbiMed, Alexandria Venture Investments, Foresite Capital
Description:
Odyssey Therapeutics is a biotechnology company pioneering the efficient development of next-generation immunomodulators and oncology medicines. Odyssey is making a transformational impact on the field of drug discovery and is accelerating the path to clinical development to drive the creation of more effective precision medicines. The company's integrated drug-hunting engine is designed to accelerate drug discovery by unlocking targets with great potential and minimizing attrition.
$487M
$10M to $50M
Cambridge, Massachusetts, United States
2021-01-01
David Pompliano, Gary Glick
11-50
2023-12-05
Private
© 2025 bioDAO.ai